km.idaeo.ai · IDAEO 知識庫

🏛 本記事はテーマ館「reports」の所蔵です →

洗口液はどう選ぶ？歯周病ならどれを使う？｜證據鏈

km 編輯部2026-08-13約57分で読了
#證據鏈#牙醫KM#牙周#兒童

本頁是〈洗口液はどう選ぶ？歯周病ならどれを使う？〉的事實單元帳：每一條主張對應的來源、證據等級、地域與期間、原文引句與限制，逐條攤開。

洗口液はどう選ぶ？歯周病ならどれを使う？｜證據鏈

F-Units（事実単位台帳）

  • F1｜confidence: verified｜basis: peer_reviewed（PMID 30968949、Cochrane システマティックレビュー）｜period: 2019-01-16 まで検索、2019 年刊行｜geo: universal｜span: 「As dental plaque is the primary cause, self-administered daily mechanical disruption and removal of plaque is important for oral health」「Toothbrushing can remove supragingival plaque on the facial and lingual/palatal surfaces, but special devices (such as floss, brushes, sticks, and irrigators) are often recommended to reach into the interdental area」「We included 35 RCTs (3929 randomised adult participants)」「Low-certainty evidence suggested that flossing, in addition to toothbrushing, may reduce gingivitis (measured by gingival index (GI)) at one month (SMD -0.58, 95% confidence interval (CI) -1.12 to -0.04; 8 trials, 585 participants), three months or six months」｜caveat: 参加者の多くはベースライン時の歯肉炎症が軽度であった；著者はエビデンスの確実性を低〜非常に低いと評価した；歯間部う蝕を評価した試験はなく、大半の試験は歯周炎も評価していない
  • F2｜confidence: verified｜basis: clinical_guideline（PMID 25639948、第 11 回欧州歯周病学ワークショップ第 1 グループのコンセンサス報告）｜period: 2015 年刊行｜geo: universal｜span: 「an appropriate periodontal diagnosis is needed before submission of individuals to professional preventive measures and determines the selection of the type of preventive care」「preventive measures are not sufficient for treatment of periodontitis」「repeated and individualized oral hygiene instruction and professional mechanical plaque (and calculus) removal are important components of preventive programs」｜caveat: コンセンサス報告であり、修正版 GRADE により評価されている；集団および臨床実践レベルの推奨であって、個々の患者に対する処方の根拠ではない
  • F3｜confidence: verified｜basis: peer_reviewed（PMID 26113099、システマティックレビューおよびメタ解析）｜period: 2014-07 まで検索、2015 年刊行｜geo: universal｜span: 「The panel included 72 articles on the effectiveness of SRP with or without the following: systemic antimicrobials, a systemic host modulator (subantimicrobial-dose doxycycline), locally delivered antimicrobials (chlorhexidine chips, doxycycline hyclate gel, and minocycline microspheres), and a variety of nonsurgical lasers」「the panel found approximately a 0.5-millimeter average improvement in CAL with SRP」「Combinations of SRP with assorted adjuncts resulted in a range of average CAL improvements between 0.2 and 0.6 mm over SRP alone」｜caveat: 対象集団は慢性歯周炎患者である；列挙された補助療法はいずれも洗口液ではない；著者は補助療法の多くについて効果の確実性を低いと評価した
  • F4｜confidence: verified｜basis: peer_reviewed（PMID 33010026、システマティックレビューおよびネットワークメタ解析）｜period: 2020-05-31 まで検索、2020 年刊行｜geo: universal｜span: 「School of Dentistry, National Taiwan University, Taipei, Taiwan」「Twenty-two studies were included」「Significantly greater PPD reduction was achieved in chlorhexidine chip group (WMD: 0.65 mm, 95% CI: 0.21-1.10) and tetracycline fibre group (WMD: 0.64 mm, 95% CI: 0.20-1.08) over 6-month follow-up」「Adjunctive local antimicrobial agents achieved small additional PPD reduction and CAL gain in residual pockets for a follow-up of up to 6 months」｜caveat: 対象は歯周支持療法中になお残存ポケットがある患者に限られる；介入はポケット内に留置する局所投与であり、洗口経路は同解析の比較範囲に含まれない
  • F5｜confidence: verified｜basis: clinical_guideline（PMID 32383274、EFP S3 レベルの臨床実践ガイドライン）｜period: 2020 年刊行｜geo: universal｜span: 「The S3 CPG approaches the treatment of periodontitis (stages I, II and III) using a pre-established stepwise approach to therapy that, depending on the disease stage, should be incremental, each including different interventions」「supra- and sub-gingival instrumentation, with and without adjunctive therapies」｜caveat: ガイドライン全文はペイウォール内にあり、本機では取得できなかったため、本項目は PubMed 抄録のみを逐語引用しており、ガイドライン全文の内容へ拡張してはならない；病期および介入の個別適用には臨床判断が必要である
  • F6｜confidence: verified｜basis: clinical_guideline（PMID 25683242、第 11 回欧州歯周病学ワークショップの序論・目的報告）｜period: 2015 年刊行｜geo: universal｜span: 「understanding the limitations of self-medication with oral health care products without a diagnosis of the underlying condition」「a need to communicate to the public the critical importance of gingival bleeding as an early sign of disease」｜caveat: ワークショップレベルの公衆衛生上の推奨であり、個別の薬剤使用指示ではない
  • F7｜confidence: verified｜basis: peer_reviewed（PMID 31869441、EFP 委託のシステマティックレビューおよびメタ解析）｜period: 2020 年刊行｜geo: universal｜span: 「Meta-analyses included 70 studies of adjunctive antiseptics」「Compared with mechanical plaque control alone, adjuncts yielded statistically significant reductions in gingival index (n = 72; SMD = -1.268; 95% CI [-1.489; -1.047]; p < .001; I2 = 96.2%)」「Mouthrinses resulted in greater reductions in per cent plaque compared with dentifrices (meta-regression, coefficient = 13.80%; 95% CI [2.40%; 25.10%]; p = .020)」「The antiseptic agents were similarly effective in reducing gingivitis and plaque in patients with dental plaque-induced gingivitis (intact periodontium) or previously treated periodontitis with gingival inflammation」｜caveat: 異質性は極めて高い（各項目の I² は 95.1%〜96.9%）；6 か月間の家庭使用 RCT を統合した結果である；統計学的有意差は個人が知覚できる差を意味しない
  • F8｜confidence: verified｜basis: peer_reviewed（PMID 25495592、システマティックレビューおよびメタ解析）｜period: 2015 年刊行｜geo: universal｜span: 「87 articles with 133 comparisons, were included in the review」「formulations with specific agents for chemical plaque control provide statistically significant improvements in terms of gingival, bleeding and plaque indices」｜caveat: 著者は結論で顕著な異質性が存在すると明記している；6 か月間の家庭使用 RCT を統合した結果である
  • F9｜confidence: verified｜basis: peer_reviewed（PMID 28362061、Cochrane システマティックレビュー）｜period: 2016-09-28 まで検索、2017 年刊行｜geo: universal｜span: 「We included 51 studies that analysed a total of 5345 participants」「One study was assessed as being at unclear risk of bias, with the remaining 50 being at high risk of bias」「After 4 to 6 weeks of use, chlorhexidine mouthrinse reduced gingivitis (Gingival Index (GI) 0 to 3 scale) by 0.21 (95% CI 0.11 to 0.31) compared to placebo, control or no mouthrinse (10 trials, 805 participants with mild gingival inflammation (mean score 1 on the GI scale) analysed, high-quality evidence)」｜caveat: 効果量は機械的口腔衛生に上乗せした「追加」効果であり、洗口液単独使用の効果ではない
  • F10｜confidence: verified｜basis: peer_reviewed（PMID 28362061、同上）｜period: 2017 年刊行｜geo: universal｜span: 「Plaque was measured by different indices and the SMD at 4 to 6 weeks was 1.45 (95% CI 1.00 to 1.90) standard deviations lower in the chlorhexidine group (12 trials, 950 participants analysed, high-quality evidence), indicating a large reduction in plaque」｜caveat: 歯垢は代替指標であり、臨床アウトカム指標ではない
  • F11｜confidence: verified｜basis: peer_reviewed（PMID 28362061、同上）｜period: 2017 年刊行｜geo: universal｜span: 「a reduction in gingivitis in individuals with mild gingival inflammation on average (mean score of 1 on the 0 to 3 GI scale) that was not considered to be clinically relevant」「There is insufficient evidence to determine the reduction in gingivitis associated with chlorhexidine mouthrinse use in individuals with mean GI scores of 1.1 to 3 indicating moderate or severe levels of gingival inflammation」「There is no evidence that one concentration of chlorhexidine rinse is more effective than another」｜caveat: 「臨床的意義が認められない」との評価は、軽度の歯肉炎症集団における歯肉指数を対象としたものであり、「無効」または「使用不要」と外挿してはならない；中等度〜重度の集団の結論にも外挿してはならない
  • F12｜confidence: verified｜basis: peer_reviewed（PMID 28362061、同上）｜period: 2017 年刊行｜geo: universal｜span: 「There was a large increase in extrinsic tooth staining in participants using chlorhexidine mouthrinse at 4 to 6 weeks」「The SMD was 1.07 (95% CI 0.80 to 1.34) standard deviations higher (eight trials, 415 participants analysed, moderate-quality evidence) in the chlorhexidine mouthrinse group」「Rinsing with chlorhexidine mouthrinse for 4 weeks or longer causes extrinsic tooth staining」｜caveat: 外因性着色であり、歯そのものの変色ではない；本カードは、除去できるか否か、または除去方法について何ら主張しない
  • F13｜confidence: verified｜basis: peer_reviewed（PMID 28362061、同上）｜period: 2017 年刊行｜geo: universal｜span: 「The adverse effects most commonly reported in the included studies were taste disturbance/alteration (reported in 11 studies), effects on the oral mucosa including soreness, irritation, mild desquamation and mucosal ulceration/erosions (reported in 13 studies) and a general burning sensation or a burning tongue or both (reported in nine studies)」「Results for the effect of chlorhexidine mouthrinse on calculus formation were inconclusive」｜caveat: 採用研究における報告頻度であり、発生率ではない；研究の多くは有害反応の検出を主目的として設計されていない
  • F14｜confidence: verified｜basis: peer_reviewed（PMID 35762364、システマティックレビューおよびメタ解析）｜period: 2021-12-07 まで検索、2022 年刊行｜geo: universal｜span: 「Fourteen studies were deemed eligible for inclusion, reporting on a total of 602 patients with an age range of 11-35 years」「The experimental solution was a 0.06%, 0.12%, or 0.2% CHX mouthwash with the control either a placebo mouthwash or a selection from a variety of mouthwashes」「Treatment duration varied from 1 day to almost 5 months and the follow-up period varied from 1 min to 5 months」｜caveat: 対象集団は固定式矯正装置による治療中の者に限られる；治療期間と追跡期間の幅が大きく、長期使用の安全性を示すエビデンスとはみなせない
  • F15｜confidence: verified｜basis: peer_reviewed（PMID 26227646、メタ解析）｜period: 1980〜2012 年の試験を採用、2015 年刊行｜geo: universal｜span: 「All industry-sponsored clinical trials investigating the antigingivitis and antiplaque effects of essential oil (EO)-containing mouthrinses conducted from 1980 to 2012 were reviewed; 29 of 32 studies met the inclusion criteria of 6 months or longer duration, randomized, observer-masked, placebo-controlled, and with individual-level site-specific data」「The summary percentage reductions in whole-mouth mean gingivitis and plaque at 6 months were 16.0 (95% CI, 11.3-20.7) and 27.7 (95% CI, 22.4-32.9), respectively」｜caveat: 組入れ条件そのものが業界スポンサー付き試験であるため、資金提供元は解釈時に必ず開示すべき制約である；本カードは同論文の製品レベルの表現を引用しない
  • F16｜confidence: verified｜basis: peer_reviewed（PMID 27628316、メタ解析およびメタ回帰）｜period: 2016-04 まで検索、2016 年刊行｜geo: universal｜span: 「From 3045 citations, 16 studies were included」「Mean QHI (WMD=-0.86, 95%CI -1.05 to -0.66) and MGI (WMD=-0.52, 95%CI -0.67 to -0.37) were lower for EO+MPC than placebo+MPC」「The analysis of risk of bias suggested that the quality of the studies ranged from moderate to low」「High heterogeneity (I2>95%) was found and explained」｜caveat: 同論文は別途「臨床的意義」の節に製品レベルの推奨調の結論文を記載しているが、本カードはコンプライアンス上の禁止事項に従い、これを引用も言い換えも改変もしない
  • F17｜confidence: verified｜basis: peer_reviewed（PMID 33185736、システマティックレビューおよびメタ解析）｜period: 2021 年刊行｜geo: universal｜span: 「Eight studies were included」「The meta-analysis demonstrated that groups that used CPC displayed a significantly greater reduction in the plaque index score (MD; 95% confidence interval [95%CI]: - 0.70; - 0.83 to - 0.57) and in the gingival index (MD; 95%CI: - 0.38; - 0.47 to - 0.28) when compared to placebo」「high heterogeneity was observed in both analyses (I2 = 89% and I2 = 98%, respectively)」「demonstrating the potential to compensate for the limitations of interproximal plaque control」｜caveat: 結果は歯間面に限られる；原文の数値は負値（低下を示す）であり、本カードでは「0.70 低下」などの日本語表現とし、区間を変化量の大きさ順に並べたが、数値自体は変更していない；異質性は極めて高く、区間の解釈には慎重を要する
  • F18｜confidence: verified｜basis: peer_reviewed（PMID 27472005、Cochrane システマティックレビュー）｜period: 2016-04-22 まで検索、2016 年刊行｜geo: universal｜span: 「In this review, we included 37 trials involving 15,813 children and adolescents」「All trials tested supervised use of fluoride mouthrinse in schools, with two studies also including home use」「Most studies (28) were at high risk of bias, and nine were at unclear risk of bias」「the D(M)FS pooled PF was 27% (95% confidence interval (CI), 23% to 30%; I(2) = 42%) (moderate quality evidence)」「The pooled estimate of D(M)FT PF was 23% (95% CI, 18% to 29%; I² = 54%)」「We found limited information concerning possible adverse effects or acceptability of the treatment regimen in the included trials」｜caveat: 効果は学校での監督下使用という状況で得られた；著者は結果が他の状況にも適用され得るとしているが、監督のない家庭使用でのう蝕予防効果の大きさは、より不明確である
  • F19｜confidence: verified｜basis: clinical_guideline（PMID 24177407、ADA 科学評議会専門家パネルの臨床推奨）｜period: 2012-10 まで検索、2013 年刊行｜geo: universal｜span: 「The panel recommends the following for people at risk of developing dental caries」「a prescription-strength, home-use 0.05 percent fluoride gel or paste or 0.09 percent fluoride mouthrinse for patients 6 years or older」「Only 2.26 percent fluoride varnish is recommended for children younger than 6 years」｜caveat: 推奨の対象は「う蝕リスクがある人」であり、全人口ではない；製品濃度、分類、入手可能性は国によって異なるため、所在地の製品表示および歯科医師の指示に従う必要がある；同論文には訂正（用量の誤記）も記録されている
  • F20｜confidence: verified｜basis: peer_reviewed（PMID 20091645、Cochrane システマティックレビュー）｜period: 2009-03-09 まで検索、2010 年刊行｜geo: universal｜span: 「A possible adverse effect associated with the use of topical fluoride is the development of dental fluorosis due to the ingestion of excessive fluoride by young children with developing teeth」「Children under the age of 6 years at the time topical fluorides were used」「25 studies were included: 2 RCTs, 1 cohort study, 6 case-control studies and 16 cross-sectional surveys」「Only one RCT was judged to be at low risk of bias」「There should be a balanced consideration between the benefits of topical fluorides in caries prevention and the risk of the development of fluorosis」｜caveat: 入手可能なエビデンスの多くは軽度の歯のフッ素症に焦点を当てる；同レビューは 2024 年に更新版が公表されており、本カードの数値は 2010 年版に基づくため、本格展開前に更新版で結論が変わっていないか再確認する必要がある
  • F21｜confidence: verified｜basis: peer_reviewed（PMID 36156769、Cochrane システマティックレビュー）｜period: 2021-09-28 まで検索、2022 年刊行｜geo: universal｜span: 「We included 49 trials with 6771 participants」「rinsing with chlorhexidine mouthrinses (0.12% and 0.2% concentrations) both before and 24 hours after extraction(s) substantially reduced the risk of developing dry socket with an OR of 0.38 (95% CI 0.25 to 0.58; P < 0.00001; 6 trials, 1547 participants; moderate-certainty evidence)」「The present review found some evidence for the association of minor adverse reactions with use of 0.12%, 0.2% chlorhexidine mouthrinses (alteration in taste, staining of teeth, stomatitis) though most studies were not designed explicitly to detect the presence of hypersensitivity reactions to mouthwash as part of the study protocol」「all but five studies included in the present review included participants undergoing extraction of third molars, most of which were undertaken by oral surgeons」｜caveat: 歯科医師の指示期間中の特定状況に限った用法であり、日常ケアの根拠ではない；6,771 人はレビュー全体の参加者数で、ドライソケット予防を目的とする chlorhexidine 洗口の比較は 6 試験、1,547 人のみを含む
  • F22｜confidence: verified｜basis: peer_reviewed（PMID 31825092、Cochrane システマティックレビュー）｜period: 2019-04 まで検索、2019 年刊行｜geo: universal｜span: 「We included 44 trials in the review with 1809 participants comparing an intervention with a placebo or a control」「We excluded studies including patients with halitosis secondary to systemic disease and halitosis-masking interventions」「for mouthwash containing chlorhexidine and zinc acetate versus placebo mouthwash, the evidence was very uncertain for the outcome dentist-reported OLT scores (MD -0.20, 95% CI -0.58 to 0.18; 1 trial, 44 participants; very low-certainty evidence)」「We found low- to very low-certainty evidence to support the effectiveness of interventions for managing halitosis compared to placebo or control for the OLT and patient-reported outcomes tested」「We were unable to draw any conclusions regarding the superiority of any intervention or concentration」｜caveat: 多くは 1〜4 週間の短期追跡であり、1 件のみが 3 か月の結果を報告している；重度歯周炎の参加者も除外されている
  • F23｜confidence: verified｜basis: peer_reviewed（PMID 31655832、システマティックレビュー）｜period: 2020 年刊行｜geo: universal｜span: 「8 studies were included in the qualitative analysis which include a total of 43,499 subjects: two meta-analyses, a clinical trial, three case-control studies and two cohort studies」「It cannot be guaranteed that the use of mouthwash represents an independent risk factor for the development of head and neck cancer」「the risk does increase when it occurs in association with other carcinogenic risk factors」｜caveat: 定性的統合であり、メタ解析は行われていない；採用研究の結果は一致していない（1 研究で関連あり、2 研究で高頻度使用時に関連あり、3 研究で関連なし）
  • F24｜confidence: verified｜basis: peer_reviewed（PMID 29411737、症例報告およびシステマティック文献レビュー）｜period: 2018 年刊行｜geo: universal｜span: 「Several cases of allergic reactions to chlorhexidine have been reported, both in the general population and in workers」「Our systematic literature review identified 14 cases of occupational chlorhexidine-induced allergy among HCWs; in these cases, the clinical presentation was mild and the symptoms resolved」｜caveat: 対象集団は職業曝露を受けた医療従事者であり、一般の洗口使用者における発生率へ外挿してはならない；同レビューが採用したのは職業性の症例報告および症例集積のみで、分母がなく、リスクを算出できない
  • F25｜confidence: verified｜basis: peer_reviewed（PMID 35998741、システマティックレビューおよびメタ解析）｜period: 2000-01〜2022-01 を検索、2022 年刊行｜geo: universal｜span: 「A total of 20 studies were included in the meta-analysis」「The prevalence of periodontitis among pregnancy was 40% (95% Confidence Interval (CI): [0.15, 1.00])」「the prevalence rates of BOP (+) and PD≥4 mm presented a gradual increase throughout pregnancy」「However, heterogeneity was high among included studies」｜caveat: 信頼区間は極めて広く（0.15〜1.00）、異質性も高い；この統合有病率は方向性を理解するための参考にとどまり、いずれかの国または集団の推定値とみなしてはならない
  • F26｜confidence: verified｜basis: peer_reviewed（PMID 28605006、Cochrane システマティックレビュー）｜period: 2016-10 まで検索、2017 年刊行｜geo: universal｜span: 「gum conditions tend to worsen during pregnancy」「There were 15 RCTs (n = 7161 participants) meeting our inclusion criteria」「All the included studies were at high risk of bias mostly due to lack of blinding and imbalance in baseline characteristics of participants」「It is not clear if periodontal treatment during pregnancy has an impact on preterm birth (low-quality evidence)」「There is low-quality evidence that periodontal treatment may reduce low birth weight (< 2500 g), however, our confidence in the effect estimate is limited」｜caveat: 本項目は「歯周治療」のエビデンスであり、「洗口液」のエビデンスではないため、相互に置き換えてはならない
  • F27｜confidence: verified｜basis: peer_reviewed（PMID 26876277、システマティックレビュー）｜period: 2015-02 まで検索、2017 年刊行｜geo: universal｜span: 「Of the total 206 articles searched, three randomized controlled trials evaluating neem-based herbal mouthrinses were included」「These studies reported that neem mouthrinse was as effective as chlorhexidine mouthrinse when used as an adjunct to toothbrushing in reducing plaque and gingival inflammation in gingivitis patients」「the quality of reporting and evidence along with methods of studies was generally flawed with unclear risk of bias」「the evidence concerning the clinical use of neem mouthrinses is lacking and needs further reinforcement with high-quality randomized controlled trials」｜caveat: RCT は 3 件のみで、異質性が顕著なためメタ解析は行われていない；chlorhexidine と同程度の効果との記述は、採用研究が報告した内容であり、確実性の高い結論ではない
  • F28｜confidence: verified｜basis: peer_reviewed（PMID 32383334、システマティックレビューおよびメタ解析）｜period: 2020-04 まで検索、2020 年刊行｜geo: universal｜span: 「Seven RCTs were included」「significant heterogeneity for both GI (χ2 = 72.77, P < .0001, I2 = 91.76%) and PI (χ2 = 153.67, P < .0001, I2 = 96.10%) was observed between both TRP-MW and CHX-MW groups」「The overall mean difference for both GI (WMD = -0.29, 95% CI = -0.40 to -0.17, P < .001) and PI (WMD = -0.43, 95% CI = -0.54 to -0.31, P < .001) was statistically significant between TRP-MW and CHX-MW at follow-up, respectively」｜caveat: 異質性は極めて高く（I² 90% 超）、統合推定値の解釈には極めて慎重を要する；本カードは同論文のコストおよび入手可能性に関する記述を引用しない
  • F29｜confidence: verified｜basis: internal_dataset｜period: 2025-03〜2026-08 GSC｜geo: universal｜span: backlog #6「漱口水推薦」等 7 詞項合計曝光 272,409，來源站（1 站）｜caveat: 表示回数はアセット単位の数値であり、重複を除いたトラフィックではない；掲載対象リストはキューページの #6 欄に従い、追加・削除を禁止する；本項目は公開用変換時に項目全体を削除し、「本テーマの選定根拠は内部検索データの分析である」の一文に置き換える
  • F30｜confidence: 構造的整理（編集フレームであり、外部の事実主張ではありません）｜basis: editorial_framework｜period: 2026-08-06｜geo: universal｜span: 「四つの振り分け（むし歯予防／歯肉の炎症／診断済みの歯周病／口臭）」、「まず何の代わりにならないかを述べ、次に成分、最後に適さない人を述べる」という叙述順序、および「診断→機械的治療→補助的抗菌」という三段階の並べ方は、本サイトが F1 から F28 の文献をもとに整理した対話用の枠組みです｜caveat: 臨床的な判断基準ではなく、診断ツールでもなく、製品選びの指南でもありません。歯科医師の評価に代わるものではありません

出典一覧

取用日期均為 2026-08-06；PubMed 條目以 E-utilities efetch 取得摘要原文逐字對照，全卡 F-Unit 英文 span 已以 `km-gate.py --spans` 回丟原文逐字比對。付費牆全文未取回者（F5 之指引全文）僅依摘要引用，已於該條 caveat 註明。

  1. Worthington HV, et al. Home use of interdental cleaning devices, in addition to toothbrushing, for preventing and controlling periodontal diseases and dental caries. Cochrane Database Syst Rev. 2019. PMID 30968949
  2. Tonetti MS, et al. Principles in prevention of periodontal diseases: Consensus report of group 1 of the 11th European Workshop on Periodontology. J Clin Periodontol. 2015. PMID 25639948
  3. Smiley CJ, et al. Systematic review and meta-analysis on the nonsurgical treatment of chronic periodontitis by means of scaling and root planing with or without adjuncts. J Am Dent Assoc. 2015. PMID 26113099
  4. Wang CY, et al. Adjunctive local treatments for patients with residual pockets during supportive periodontal care: A systematic review and network meta-analysis. J Clin Periodontol. 2020. PMID 33010026
  5. Sanz M, et al. Treatment of stage I-III periodontitis — The EFP S3 level clinical practice guideline. J Clin Periodontol. 2020. PMID 32383274
  6. Tonetti MS, et al. Primary and secondary prevention of periodontal and peri-implant diseases: Introduction to, and objectives of the 11th European Workshop on Periodontology consensus conference. J Clin Periodontol. 2015. PMID 25683242
  7. Figuero E, et al. Efficacy of adjunctive therapies in patients with gingival inflammation: A systematic review and meta-analysis. J Clin Periodontol. 2020. PMID 31869441
  8. Serrano J, et al. Efficacy of adjunctive anti-plaque chemical agents in managing gingivitis: a systematic review and meta-analysis. J Clin Periodontol. 2015. PMID 25495592
  9. James P, et al. Chlorhexidine mouthrinse as an adjunctive treatment for gingival health. Cochrane Database Syst Rev. 2017. PMID 28362061（對應 F9、F10、F11、F12、F13）
  10. Karamani I, et al. Chlorhexidine Mouthwash for Gingivitis Control in Orthodontic Patients: A Systematic Review and Meta-Analysis. Oral Health Prev Dent. 2022. PMID 35762364
  11. Araujo MWB, et al. Meta-analysis of the effect of an essential oil-containing mouthrinse on gingivitis and plaque. J Am Dent Assoc. 2015. PMID 26227646
  12. Haas AN, et al. Essential oils-containing mouthwashes for gingivitis and plaque: Meta-analyses and meta-regression. J Dent. 2016. PMID 27628316
  13. Langa GPJ, et al. The effect of cetylpyridinium chloride mouthrinse as adjunct to toothbrushing compared to placebo on interproximal plaque and gingival inflammation — a systematic review with meta-analyses. Clin Oral Investig. 2021. PMID 33185736
  14. Marinho VC, et al. Fluoride mouthrinses for preventing dental caries in children and adolescents. Cochrane Database Syst Rev. 2016. PMID 27472005
  15. Weyant RJ, et al. Topical fluoride for caries prevention: executive summary of the updated clinical recommendations and supporting systematic review. J Am Dent Assoc. 2013. PMID 24177407
  16. Wong MC, et al. Topical fluoride as a cause of dental fluorosis in children. Cochrane Database Syst Rev. 2010. PMID 20091645
  17. Daly BJ, et al. Local interventions for the management of alveolar osteitis (dry socket). Cochrane Database Syst Rev. 2022. PMID 36156769
  18. Kumbargere Nagraj S, et al. Interventions for managing halitosis. Cochrane Database Syst Rev. 2019. PMID 31825092
  19. Ustrell-Borràs M, et al. Alcohol-based mouthwash as a risk factor of oral cancer: A systematic review. Med Oral Patol Oral Cir Bucal. 2020. PMID 31655832
  20. Toletone A, et al. Chlorhexidine-induced anaphylaxis occurring in the workplace in a health-care worker: case report and review of the literature. Med Lav. 2018. PMID 29411737
  21. Chen P, et al. Prevalence of periodontal disease in pregnancy: A systematic review and meta-analysis. J Dent. 2022. PMID 35998741
  22. Iheozor-Ejiofor Z, et al. Treating periodontal disease for preventing adverse birth outcomes in pregnant women. Cochrane Database Syst Rev. 2017. PMID 28605006
  23. Dhingra K, Vandana KL. Effectiveness of Azadirachta indica (neem) mouthrinse in plaque and gingivitis control: a systematic review. Int J Dent Hyg. 2017. PMID 26876277
  24. AlJameel AH, Almalki SA. Effect of triphala mouthrinse on plaque and gingival inflammation: A systematic review and meta-analysis of randomized controlled trials. Int J Dent Hyg. 2020. PMID 32383334
  25. 內部數據：`analysis/reports/km-dental-backlog.md` #6 附錄（詞×站×曝光逐筆可對帳）
  26. 編輯框架：本サイト「四路分流」與敘事順序（無外部來源，標示為結構性整理）

内部引用チェーン

  • 歯肉の腫れ・出血をどう区分し、いつ受診するか：歯肉の腫れや痛みを早く抑えるには？いつ受診すべき？（KM-DENTAL-05）
  • 抜歯創の治癒の流れとドライソケットの警告サイン：抜歯後の穴はどのくらいで治る？（KM-DENTAL-01）
  • むし歯の原因と処置（フッ化物洗口液が対象にするもの）：むし歯は必ず詰める？詰め方は？（KM-DENTAL-12）
公開ゲートの注意：本カードは draft です。zh-Hans、en、ja がそろうまで km_entries に入れてはなりません。公開変換時には F29（internal_dataset）と frontmatter の合計曝光欄を除去します。F5 の指針全文が取得できない間は「抄録のみに依拠」の位置づけを維持し、指針全文の内容へ拡張してはなりません。F20 の Cochrane には 2024 年更新版があるため、展開または改訂前に結論が変わるか再確認します。

FAQ

洗口液を使えば歯みがきやフロスは不要ですか？
**不要にはなりません。** 毎日の機械的歯垢除去が基礎です。歯みがきは頬側と舌側／口蓋側を扱い、歯間部には通常フロスや歯間ブラシが必要です [F1]。本カードの洗口液研究は、機械的清掃への上乗せ効果を検証しています [F7][F8]。フロス追加は 1、3、6 か月の歯肉指数を低下させる可能性がありますが、確実性は低いものです [F1]。
洗口液を使えば歯みがきやフロスは不要ですか？ — **不要にはなりません。** 毎日の機械的歯垢除去が基礎です。歯みがきは頬側と舌側／口蓋側を扱い、歯間部には通常フロスや歯間ブラシが必要です [F1]。本カードの洗口液研究は、機械的清掃への上乗せ効果を検証しています [F7][F8]。フロス追加は 1、3、6 か月の歯肉指数を低下させる可能性がありますが、確実性は低いものです [F1]。
Can I use mouthwash instead of brushing or flossing? — **No.** Daily mechanical plaque removal is foundational. Brushing reaches facial and lingual/palatal surfaces; interdental areas usually need floss or interdental brushes [F1]. The mouthwash studies here test an additional effect on top of mechanical cleaning [F7][F8]. Adding floss to brushing may reduce gingivitis at 1, 3, and 6 months, with low-certainty evidence [F1].
歯周病は抗菌洗口液で治りますか？
**治りません。順番が逆です。** 予防措置は歯周炎治療に不十分です [F2]。EFP 指針は歯肉縁上・縁下の器械的デブライドメントを中心とする段階的治療で、補助療法は追加可能ですが代替ではありません [F5]。SRP は平均約 0.5 mm の CAL 改善、補助療法は 0.2〜0.6 mm の追加改善で、残存ポケットの小さな追加効果は chlorhexidine チップ 0.65 mm とテトラサイクリン線維 0.64 mm でした [F3][F4]。診断と評価が必要です。
歯周病は抗菌洗口液で治りますか？ — **治りません。順番が逆です。** 予防措置は歯周炎治療に不十分です [F2]。EFP 指針は歯肉縁上・縁下の器械的デブライドメントを中心とする段階的治療で、補助療法は追加可能ですが代替ではありません [F5]。SRP は平均約 0.5 mm の CAL 改善、補助療法は 0.2〜0.6 mm の追加改善で、残存ポケットの小さな追加効果は chlorhexidine チップ 0.65 mm とテトラサイクリン線維 0.64 mm でした [F3][F4]。診断と評価が必要です。
Will an antimicrobial mouthwash cure periodontal disease? — **No; that reverses the required sequence.** Preventive measures are insufficient to treat periodontitis [F2]. EFP guidance uses stepwise treatment centred on supra- and subgingival instrumentation, with or without adjunctive therapies [F5]. SRP averages about 0.5 mm CAL improvement; adjuncts add 0.2 to 0.6 mm, while the small residual-pocket effects cited concern locally delivered chlorhexidine chips (0.65 mm) and tetracycline fibres (0.64 mm) [F3][F4]. Dental diagnosis and assessment are required.
chlorhexidine 洗口液はずっと使えますか？
**記録された代償は、自己判断の長期使用を支持しません。** 4 週間以上で外因性歯牙着色が起こり、4〜6 週で標準化平均差は 1.07 でした [F12]。味覚異常（11 研究）、粘膜への影響（13 研究）、灼熱感（9 研究）も多く報告されました [F13]。特定濃度の優越性は示されず、中等度〜重度歯肉炎への証拠も不十分です [F11]。濃度、頻度、期間は歯科医師が決めます [F6]。
chlorhexidine 洗口液はずっと使えますか？ — **記録された代償は、自己判断の長期使用を支持しません。** 4 週間以上で外因性歯牙着色が起こり、4〜6 週で標準化平均差は 1.07 でした [F12]。味覚異常（11 研究）、粘膜への影響（13 研究）、灼熱感（9 研究）も多く報告されました [F13]。特定濃度の優越性は示されず、中等度〜重度歯肉炎への証拠も不十分です [F11]。濃度、頻度、期間は歯科医師が決めます [F6]。
Can I keep using chlorhexidine mouthwash indefinitely? — **The documented trade-offs point against unsupervised long-term use.** Rinsing for 4 weeks or longer causes extrinsic tooth staining, with SMD 1.07 at 4 to 6 weeks [F12]. Other commonly reported effects were taste disturbance (11 studies), oral-mucosal effects including soreness, irritation, ulceration or erosions (13 studies), and burning sensation (9 studies) [F13]. No concentration has evidence of superiority, and evidence is insufficient for moderate-to-severe gingival inflammation [F11]. A dentist should set concentration, frequency, and duration [F6].

出典アンカー

この記事を引用

km 編輯部・《洗口液はどう選ぶ？歯周病ならどれを使う？｜證據鏈》・IDAEO 知識庫・2026-08-13・https://km.idaeo.ai/post/reports/dental-mouthwash-selection-evidence

関連記事

更新 2026-08-13T14:17:27.409Z · server-rendered · four-language · IDAEO 知識庫